HVA / VMA Ratio

Your body constantly produces and breaks down three signaling chemicals that shape mood, alertness, blood pressure, and stress response: dopamine, noradrenaline, and adrenaline. When these are broken down, they leave behind two distinct waste products in your urine, and the ratio between them can carry information that neither number alone provides.

This urine test compares HVA (homovanillic acid), the main leftover from dopamine, against VMA (vanillylmandelic acid), the main leftover from adrenaline and noradrenaline. In specific clinical settings, the ratio can help flag rare catecholamine-secreting tumors or inherited enzyme problems that standard labs would not catch.

How to Read the Ratio

HVA and VMA come from the same family of signaling chemicals, but they reflect different branches. HVA tracks dopamine breakdown. VMA tracks the adrenaline and noradrenaline branch. The enzyme that converts dopamine into noradrenaline is called dopamine beta-hydroxylase. When that enzyme works normally, dopamine becomes noradrenaline efficiently, and the ratio stays balanced. When the enzyme is sluggish or blocked, dopamine piles up and gets broken down into HVA instead, pushing the ratio higher.

A higher ratio suggests metabolism is leaning toward the dopamine side. A lower ratio suggests it is leaning toward adrenaline and noradrenaline. There is no established clinical role for this ratio as a general wellness marker in healthy adults, so meaning depends entirely on context: symptoms, known risk conditions, and what other catecholamine markers show.

Neuroblastoma and Related Tumors

This test was developed and is most often used in the workup of neuroblastoma, a tumor of nerve tissue that almost always appears in children. Published estimates of the sensitivity of HVA plus VMA together range from roughly 73 to 85 percent, with broader catecholamine metabolite panels reaching higher sensitivity. The ratio can carry extra information beyond the absolute levels.

A high HVA relative to VMA points to a more dopaminergic tumor. These tumors are often biologically less mature and more frequently linked to MYCN amplification, a genetic change tied to worse outcomes. Research suggests the urinary HVA to VMA ratio can help identify MYCN-amplified disease. In one study, an HVA/VMA ratio greater than 2 was associated with the worst prognosis, while a ratio between 1 and 2 was associated with the best survival.

For adults, this disease association is less directly relevant, but the same biology applies to rarer adult catecholamine-producing tumors like pheochromocytoma and paraganglioma. For those workups, metanephrine-based tests are clearly preferred, and HVA/VMA serves at most as a supporting marker rather than a primary screen.

Menkes Disease and Inherited Enzyme Problems

The clearest non-tumor use of this ratio is screening for Menkes disease, an inherited disorder of copper metabolism that cripples the copper-dependent dopamine beta-hydroxylase enzyme. In affected infants, ratios were markedly elevated (reported in one series between 4.1 and 69.7) compared with healthy children, where only about 0.18 percent crossed a ratio of 4.0. The test catches a problem that routine bloodwork misses entirely.

Why a Single Reading Is Not Enough

Urinary catecholamine metabolites can fluctuate with diet, stress, time of day, and recent activity, although modern liquid chromatography mass spectrometry methods have reduced some of the dietary noise seen with older assays. A single reading captures a snapshot. Spot urine samples can be used reliably when interpreted with creatinine correction, but a one-time number outside the expected range does not establish anything on its own. The pattern over time, interpreted alongside symptoms and other markers, matters more than any one collection.

If a first result is unexpected, the standard move is to repeat the test under steady conditions before drawing any conclusions.

When Results Can Be Misleading

Several common factors can shift results without indicating real disease:

• Pre-test diet: bananas, vanilla-containing foods, and flavonol-rich foods such as onions, tomatoes, and tea have been reported to shift catecholamine metabolite measurements, although the size of the effect depends on the assay used. One published case found that olive ingestion produced a false suspicion of neuroblastoma relapse.
• Medications: ibuprofen metabolites can co-elute with VMA in capillary gas chromatography assays, distorting results. This interference is assay-specific and may not apply to modern liquid chromatography mass spectrometry methods, so check with your lab.
• Acute stress, illness, or exercise: these can temporarily shift catecholamine turnover and the ratio for hours to days.
• Collection errors: for 24-hour urine collections, missing any portion of the day distorts the result. For spot urine, results must be normalized to creatinine to be interpretable.

If you regularly take ibuprofen, recently ate foods known to affect catecholamine measurements, or are recovering from illness, retest under cleaner conditions before reading anything into a single result.

How This Fits Into a Broader Workup

For diagnosis of catecholamine-related disease, HVA and VMA alone catch most pediatric neuroblastoma cases but miss a meaningful minority. Adding more markers helps. In one study, an expanded urinary metabolite panel raised diagnostic sensitivity for neuroblastoma to roughly 95 percent compared with about 84 percent for HVA plus VMA. Plasma 3-methoxytyramine and normetanephrine reached about 97.9 percent sensitivity compared with 82.2 percent for urinary HVA plus VMA in another comparison. For pheochromocytoma in adults, plasma free metanephrines (96 to 100 percent sensitivity) and urinary fractionated metanephrines (96 to 97 percent) clearly outperform urinary VMA, which has a sensitivity of only about 46 to 77 percent. Major guidelines recommend plasma free or 24-hour urine fractionated metanephrines as the initial test for pheochromocytoma.

If a ratio comes back unexpectedly high or low, the next steps depend on what else is happening. With unexplained high blood pressure, palpitations, or sweating spells, plasma free metanephrines or a 24-hour urinary fractionated metanephrines test should follow, ideally with input from an endocrinologist. If neuroendocrine tumor risk is being tracked, imaging and additional metabolites are part of the workup. If the ratio is mildly off without symptoms, the most common cause is dietary or analytical, and a clean repeat test is usually the right move.

What This Test Is Not Meant to Do

A large infant screening program using urinary HVA and VMA was eventually abandoned because it detected many tumors that would have regressed on their own, without improving mortality. The lesson applies to adults too. This is not a general cancer screen, not a validated wellness marker, and a normal ratio does not rule out catecholamine-related disease. Treat it as one piece of a larger picture, useful when interpreted alongside symptoms, family history, and complementary markers.